ST. PAUL, Minn., Oct. 13, 2022 /PRNewswire/ — 3M Health Care’s Medical Solutions Division in the present day introduced its 3M™ V.A.C.® Therapy negative pressure wound therapy (NPWT) has surpassed a medical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the primary and solely NPWT answer to garner this variety of published studies about its therapy. It is backed by extra medical knowledge than some other model, accounting for greater than 75% of published NPWT medical evidence.
The medical studies have been carried out by wound care professionals worldwide and published in journals throughout the globe, masking a complete vary of wound sorts, wound care settings and research codecs, reminiscent of case studies, financial studies, randomized managed trials and extra.
“Clinical evidence has always been a foundational element to establishing credibility for V.A.C. Therapy and our NPWT products in the wound care community,” mentioned Ronald Silverman, M.D., 3M Health Care senior vice chairman of medical affairs and chief medical officer. “Published studies have also helped to promote adoption of NPWT and spur therapy innovations, including 3M™ Prevena™ Therapy for incision management, 3M™ Veraflo™ Therapy for instillation therapy for open wounds, 3M™ AbThera™ Open Abdomen Negative Pressure Therapy. Our team members in the field are also actively engaged with wound care experts worldwide, working right alongside clinicians to observe the changing nature of wound care and gather feedback about our products, which helps us identify opportunities for innovation.”
Today, V.A.C. Therapy is used throughout a spectrum of well being care settings, from acute care services to ambulatory surgical facilities, assisted residing services, and in sufferers’ houses. In the U.S., V.A.C. Therapy is accessible with 24/7 distant therapy monitoring to assist adherence to the therapy. 3M’s NPWT portfolio constantly evolves to satisfy clinician and affected person wants. Last yr, 3M launched the first-ever silicone-acrylic hybrid drape to be used with V.A.C. Therapy, the 3M™ Dermatac™ Drape, an innovation designed to be mild on sufferers’ pores and skin and simple for clinicians to make use of.
“Today’s wound care patients are often sicker and have more comorbidities, making their wounds more complex to treat and increasing the demands on clinicians’ time. 3M strives to provide a robust tool selection to address clinicians’ unique wound care needs and make our products easier to use to help save their valuable time — and ultimately, help transform outcomes and improve lives for wound care patients,” mentioned Dr. Silverman.
For extra info, go to www.3m.com/npwt.
About 3M
3M (NYSE: MMM) believes science helps create a brighter world for everybody. By unlocking the ability of individuals, concepts and science to reimagine what’s potential, our international workforce uniquely addresses the alternatives and challenges of our prospects, communities, and planet. Learn how we’re working to enhance lives and make what’s subsequent at 3M.com/information or on Twitter at @3M or @3MNews.
Photo – https://mma.prnewswire.com/media/1919999/3M_VAC_Therapy.jpg
Logo – https://mma.prnewswire.com/media/1343410/3M_Logo.jpg
View unique content material:https://www.prnewswire.co.uk/news-releases/3m-vac-therapy-negative-pressure-wound-therapy-achieves-key-medical-evidence-milestone-surpassing-2-000-peer-reviewed-medical-journal-studies-published-301648254.html
